Damotharan Palani, Veeruraj Anguchamy, Arumugam Muthuvel, Balasubramanian Thangavel
Faculty of Marine Sciences, Centre of Advanced Study in Marine Biology, Annamalai University, Parangipettai, 608 502 India ; Marine Biotechnology, National Institute of Ocean Technology (NIOT), Ministry of Marine Science Govt. of India, Chennai, 600 100 India.
Faculty of Marine Sciences, Centre of Advanced Study in Marine Biology, Annamalai University, Parangipettai, 608 502 India ; Centre for Ocean Research, (SU-NIOT Joint Initiative Research Centre), Sathyabama University, Rajiv Gandhi Salai, Chennai, 600 119 India.
Indian J Clin Biochem. 2016 Mar;31(1):57-67. doi: 10.1007/s12291-015-0500-6. Epub 2015 May 8.
This study is designed to isolate and purify a novel anti-clotting protein component from the venom of Enhydrina schistosa, and explore its biochemical and biological activities. The active protein was purified from the venom of E. schistosa by ion-exchange chromatography using DEAE-cellulose. The venom protein was tested by various parameters such as, proteolytic, haemolytic, phospholipase and anti-coagulant activities. 80 % purity was obtained in the final stage of purification and the purity level of venom was revealed as a single protein band of about 44 kDa in SDS-polyacrylamide electrophoresis under reducing conditions. The results showed that the Potent hemolytic activity was observed against cow, goat, chicken and human (A, B and O positive) erythrocytes. Furthermore, the clotting assays showed that the venom of E. schistosa significantly prolonged in activated partial thromboplastin time, thrombin time, and prothrombin time. Venomous enzymes which hydrolyzed casein and gelatin substrate were found in this venom protein. Gelatinolytic activity was optimal at pH 5-9 and (1)H NMR analysis of purified venom was the base line information for the structural determination. These results suggested that the E. schistosa venom holds good promise for the development of novel lead compounds for pharmacological applications in near future.
本研究旨在从裂颏海蛇毒液中分离纯化一种新型抗凝血蛋白成分,并探索其生化和生物学活性。采用DEAE - 纤维素离子交换色谱法从裂颏海蛇毒液中纯化活性蛋白。通过多种参数对毒液蛋白进行检测,如蛋白水解、溶血、磷脂酶和抗凝血活性。在纯化的最后阶段获得了80%的纯度,在还原条件下的SDS - 聚丙烯酰胺电泳中,毒液的纯度水平显示为一条约44 kDa的单一蛋白带。结果表明,该毒液对牛、山羊、鸡和人类(A、B和O阳性)红细胞具有显著的溶血活性。此外,凝血试验表明,裂颏海蛇毒液显著延长活化部分凝血活酶时间、凝血酶时间和凝血酶原时间。在这种毒液蛋白中发现了能水解酪蛋白和明胶底物的有毒酶。明胶酶解活性在pH 5 - 9时最佳,纯化毒液的(1)H NMR分析是结构测定的基线信息。这些结果表明,裂颏海蛇毒液在不久的将来有望开发出用于药理学应用的新型先导化合物。